A detailed history of Wellington Management Group LLP transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 113,205 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,205
Holding current value
$0
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
N/A
113,205 New
113,205 $0
Q1 2021

May 17, 2021

SELL
$37.62 - $60.41 $520,547 - $835,893
-13,837 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$25.0 - $46.34 $345,925 - $641,206
13,837 New
13,837 $641,000

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.